Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Investing Cash Flow

-$13.71M

TTM · Period ending: Jun 30, 2026 · USD

LCTX Investing Cash Flow

Latest reported-$13.71Mperiod endingJun 30, 2026

Latest reported-$13.71Mperiod endingJun 30, 2026

LCTX TTM Cash from Investing (-$100.00K → -$13.71M)

TTM investing cash flow

High-resolution chart · PNG

LCTX investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period ending	Investing Cash Flow (USD)
Jun 30, 2001	-9,704
Mar 31, 2001	-27,376
Dec 31, 2000	-33,402
Sep 30, 2000	-95,121
Jun 30, 2000	-90,533
Mar 31, 2000	-169,222
Dec 31, 1999	-161,719
Sep 30, 1999	-100,000
Jun 30, 1999	-100,000
Mar 31, 1999	0
Sep 30, 1998	-100,000
Jun 30, 1998	-100,000
Mar 31, 1998	-100,000
Dec 31, 1997	-100,000
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	3,000,000
Sep 30, 1996	3,000,000
Sep 30, 1995	4,900,000
Jun 30, 1995	4,900,000
Mar 31, 1995	1,900,000
Dec 31, 1994	-3,100,000
Sep 30, 1994	-3,100,000
Jun 30, 1994	-3,100,000
Mar 31, 1994	-5,100,000
Dec 31, 1993	-100,000
Sep 30, 1993	-2,000,000
Jun 30, 1993	-2,000,000
Mar 31, 1993	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.